Rigel Pharmaceuticals, Inc. <RIGL.O>: Piper Sandler Raises Target Price to $49 From $40
RIGL•Related News
IonQ, Inc.: Mizuho cuts target price to $52 from $61
IONQ•
In a global economic heatwave, beware financial wildfires: Mike Dolan
SPY•
Iran and US hit tankers in biggest wave of attacks on shipping since war began
XLE•
Crypto, banks take lobbying war to US senators' home states ahead of key vote
COIN•
Nautilus Biotechnology, Inc. <NAUT.O>: Leerink Partners initiates coverage with outperform rating; price target $4
NAUT•